GlassScriptPhysician profile
Robert N Cotterman
NPI 1972769966
$3,688.50
in general payments reported to CMS, 2019-2025
16 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2021: $20.29 · 2022: $3,159 · 2023: $71.03 · 2024: $186 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,004.63 | 2022-2025 | |
| Aroa Biosurgery Incorporated | $124.68 | 2022-2024 | |
| Medtronic Vascular, INC. | $116.07 | 2019 | |
| Tela Bio, INC. | $110.64 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $56.73 | 2025 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $41.38 | 2022 | |
| Kerecis Limited | $39.66 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Zimmer Biomet Holdings, INC. | $36.89 | 2024-2025 | Ribfix Blu Advantage, Ribfix Titan |
| Hemosonics LLC | $27.26 | 2023 | Quantra Qplus System |
| Pfizer INC. | $23.97 | 2024 | |
| Edwards Lifesciences Corporation | $23.61 | 2024 | Hemosphere |
| Kci USA, INC. | $20.29 | 2021 | |
| Teleflex LLC | $16.84 | 2022 | |
| Access Pro Medical, LLC | $16.40 | 2025 | Matriderm |
| Braintree Laboratories, INC. | $16.29 | 2024 | Suflave |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $13.16 | 2023 | Theragenesis Bilayer Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cotterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.